Concentration–response model of rilpivirine in a cohort of HIV-1-infected naive and pre-treated patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Concentration–response model of rilpivirine in a cohort of HIV-1-infected naive and pre-treated patients
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-03-19
DOI
10.1093/jac/dkz141
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data
- (2018) Amedeo Ferdinando Capetti et al. ANNALS OF PHARMACOTHERAPY
- Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine
- (2018) Nadège Néant et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies
- (2018) Josep M Llibre et al. LANCET
- Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications
- (2016) Véronique Avettand-Fènoël et al. CLINICAL MICROBIOLOGY REVIEWS
- Altered Viral Fitness and Drug Susceptibility in HIV-1 Carrying Mutations That Confer Resistance to Nonnucleoside Reverse Transcriptase and Integrase Strand Transfer Inhibitors
- (2014) Z. Hu et al. JOURNAL OF VIROLOGY
- Concentration-response Model of Lopinavir/Ritonavir in HIV-1–infected Pediatric Patients
- (2014) Naïm Bouazza et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Integrated Population Pharmacokinetic/Viral Dynamic Modelling of Lopinavir/Ritonavir in HIV-1 Treatment-Naïve Patients
- (2013) Kun Wang et al. CLINICAL PHARMACOKINETICS
- A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients
- (2012) Naïm Bouazza et al. AIDS
- Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
- (2011) Martin Bergstrand et al. AAPS Journal
- Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial
- (2011) Calvin J Cohen et al. LANCET
- Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial
- (2011) Jean-Michel Molina et al. LANCET
- Maximum Likelihood Estimation of Long-Term HIV Dynamic Models and Antiviral Response
- (2010) Marc Lavielle et al. BIOMETRICS
- Effect of intrinsic and extrinsic factors on the pharmacokinetics of TMC278 in antiretroviral-naïve, HIV-1-infected patients in ECHO and THRIVE
- (2010) HM Crauwels et al. Journal of the International AIDS Society
- Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial
- (2009) Anton L Pozniak et al. AIDS
- The Hill equation: a review of its capabilities in pharmacological modelling
- (2008) Sylvain Goutelle et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Estimating drug efficacy and viral dynamic parameters: HIV and HCV
- (2007) Alan S. Perelson et al. STATISTICS IN MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search